Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project

Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform the way suspected head and neck cancer cases are identified and referred.

At the heart of the project is the development of a symptom-based risk stratification tool—a cutting-edge approach designed to streamline referrals and guide diagnostic decisions.

Why is this study important?

The EVEREST-HN trial could reshape the patient treatment journey by:

  • Quickly identifying high-risk patients, ensuring timely access to vital investigations and care.
  • Reducing unnecessary diagnostics for low-risk patients, improving efficiency and resource use.
  • Transforming treatment pathways to enhance outcomes and improve quality of life for patients and their families.

This is more than just research—it’s a bold step towards a future where every patient gets the right care at the right time.

Get Involved

Is your centre ready to be part of this cutting-edge trial? Join us in shaping the future of head and neck cancer care.

Learn more about the EVEREST-HN project and how to participate: https://www.royalmarsden.nhs.uk/everest-hn/about-everest-hn

Together, we can make a real difference.

Help Beat Head and Neck Cancer